Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 4/28/2026 Issue ¦ Lloyds Bank plc - Series 2023-4 GBP 1,000,000,000 FRN due November 2026     ISIN Number ¦ XS2711354915 ISIN Reference ¦ 271135491 Issue Nomin GBP ¦ 1000000000 Period ¦ 2/6/2026 to 5/6/2026   Payment Date 5/6/2026 Number of Days ¦ 89 Rate ¦ 4.24519   Denomination GBP ¦ 1000   ¦ 1000000000   ¦       Amount Payable per Denomination ¦ 10.35   ¦ 10351285.21   ¦       Bank of New York  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 27.04.2026 FKU IE00B8X9NZ57  209,100.00 GBP   8,704,072.08   41.626  ...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 4/28/2026 Issue ¦ Standard Chartered PLC USD 750,000,000 FRN Perpetual     ISIN Number ¦ USG84228AT58 ISIN Reference ¦ US853254AA86 Issue Nomin USD ¦ 750000000 Period ¦ 4/30/2026 to 7/30/2026   Payment Date 7/30/2026 Number of Days ¦ 91 Rate ¦ 5.435   Denomination USD ¦ 100000   ¦ 750000000   ¦       Amount Payable per Denomination ¦ 1373.85   ¦ 10303875   ¦       Bank of New York     Rate Fix Desk...

LURE, France--(BUSINESS WIRE)--Regulatory News: Vetoquinol (Paris:VETO) : Le chiffre d’affaires pour le premier trimestre 2026 s’est élevé à 125 millions d’euros en retrait de -4,3% à données publiées, stable (-0.3%) à changes constants et en croissance de +1,2% par rapport à l’exercice précédent à changes constants et hors programme de simplifications des gammes complémentaires. L’impact des taux de changes a été historiquement élevé au cours du premier trimestre atteignant -5,2M€, principalem...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 27.04.2026 FEUD IE00BF2FL590  365,187.00 EUR  20,093,923.41   55.024  ...

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth : ALMKT) inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), annonce sa future présence lors du prochain Digestive Disease Week® (DDW) 2026, qui se tiendra du 2 au 5 mai au McCormick Place de Chicago, Illinois. Les dix résumés relatifs à Cellvizio acceptés au DDW 2026 couvrent quatre des domaines cliniques et commerciaux priori...

PARIS--(BUSINESS WIRE)--Regulatory News: TP (Paris:TEP): Chiffre d'affaires du Groupe au T1 2026 conforme aux attentes : 2 433 millions d'euros, en baisse de -2,2 % à données comparables1 (-6,9 % à données publiées), incluant un impact positif de +0,1 % lié à l'hyperinflation Core Services : chiffre d'affaires du T1 2026 en baisse de -1,7 % à données comparables (-6,4 % à données publiées) Poursuite de l'accélération des solutions de back-office et des solutions augmentées par l'IA affichant un...

LURE, France--(BUSINESS WIRE)--Regulatory News: Vetoquinol (Paris:VETO): Sales for the first quarter of 2026 amounted to €125 million, down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program. The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and Ind...

PARIS--(BUSINESS WIRE)--Regulatory News: TP (Paris:TEP): Q1 2026 Group revenue in line with expectations: €2,433 million, down -2.2% like-for-like1 (reported - 6.9%), including a positive +0.1% hyperinflation effect Core Services: Q1 2026 revenue down -1.7% LFL (reported -6.4%) Continued acceleration of back-office and AI-powered solutions posting strong double-digit growth numbers and partially offsetting the continued automation trajectory in Trust & Safety Revenue impacted by increasing...

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today highlights its extensive clinical presence at the upcoming 2026 Digestive Disease Week® (DDW), taking place May 2-5 at McCormick Place in Chicago, Illinois. Ten Cellvizio-related abstracts accepted by DDW 2026 span four of the most clinically and commercially important areas...